Announced details
Storage of umbilical cords, cord blood and other materials; regenerative medicine and cell therapy
Our group company. Details of the capital and personnel relationships are Not disclosed.
Our group company located in Singapore. Other information, including its location, representative, capital, year of establishment and business activities, is Not disclosed.
Green Mark certification (for the building housing the facilities at Mapletree Hi-Tech Park)
Singapore, Mapletree Hi-Tech Park (Kallang district)
The impact of this matter on the Company's financial results is minor
The company does not address Contract Value / Offering price.
Credence Research『South-East Asia Umbilical Cord Blood Market』
| Item | Details |
|---|---|
| Names of Products / Services Covered | Cell banking business, Cell Processing Center and Cell Cryopreservation Center (Cell Processing Center and Cell Cryopreservation Center) |
| Counterparty | STEMCELL INNOVATIONS PTE. LTD. |
| Counterparty overview | Our group company located in Singapore. Other information, including its location, representative, capital, year of establishment and business activities, is Not disclosed. |
| Relationship with the Company | Our group company. Details of the capital and personnel relationships are Not disclosed. |
| Launch date | Operations scheduled to begin after obtaining a license from Singapore's Ministry of Health (MOH) (specific timing is Not disclosed) |
| Applicable area | Storage of umbilical cords, cord blood and other materials; regenerative medicine and cell therapy |
| Award/certification name | Green Mark certification (for the building housing the facilities at Mapletree Hi-Tech Park) |
| Location | Singapore, Mapletree Hi-Tech Park (Kallang district) |
| Location scale | Approximately 450㎡ |
| Impact on Business Performance | The impact of this matter on the Company's financial results is minor |
| Source | Credence Research『South-East Asia Umbilical Cord Blood Market』 |
Items this document does not state (7)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To use the quality management and storage operations expertise accumulated in Japan to expand the cell banking business in the growing Southeast Asian market, with Singapore serving as the core hub.